Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Closing the loop: Understanding ostomy reversal rates and risks in trauma patients.

The journal of trauma and acute care surgery·2026
Same author

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same author

HIV-1 Nef generates lasting innate immune memory in haematopoietic stem and progenitor cells in vivo.

EMBO reports·2026
Same author

Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat).

Blood·2026
Same author

Inflammasome-Primed Neutrophils Aggravate Atherosclerosis in Cigarette Smoking.

Circulation research·2026
Same author

Targeting hypothalamic SIK3 to promote weight loss and improve glycemic control in mice.

Nature communications·2026

Related Experiment Video

Updated: Jul 20, 2025

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

6.4K

Pancreatic carcinosarcoma: An orthogonal analysis.

Andrew M Fleming1, Leah E Hendrick2, Evan S Glazer3

  • 1Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN; Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN.

Surgery
|July 31, 2023
PubMed
Summary

Pancreatic carcinosarcoma is rare but its incidence is increasing. Achieving resection with chemotherapy and negative lymph nodes improves survival, offering hope for this aggressive cancer.

More Related Videos

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.0K
Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma
03:55

Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma

Published on: December 29, 2023

504

Related Experiment Videos

Last Updated: Jul 20, 2025

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

6.4K
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.0K
Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma
03:55

Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma

Published on: December 29, 2023

504

Area of Science:

  • Oncology
  • Surgical Oncology
  • Cancer Research

Background:

  • Pancreatic carcinosarcoma is a rare malignancy with no established treatment guidelines.
  • This study analyzes prognostic factors to improve patient outcomes.
  • Understanding rare pancreatic cancer subtypes is crucial for advancing treatment strategies.

Approach:

  • A systematic review of reported pancreatic carcinosarcoma cases was conducted.
  • National Cancer Database and Surveillance, Epidemiology, and End Results (SEER) data were analyzed.
  • Orthogonal analysis of multiple datasets enhances the validity of findings.

Key Points:

  • Pancreatic carcinosarcoma incidence is increasing.
  • Tumor size, metastasis, and relapse negatively impact survival.
  • Resection plus chemotherapy, lymph node examination, and academic center treatment improve survival.
  • ≥2 positive lymph nodes are associated with decreased survival.

Conclusions:

  • Pancreatic carcinosarcoma has a poor prognosis but long-term survival is possible with resection.
  • Absence of relapse and a limited number of positive lymph nodes are critical for favorable outcomes.
  • Further research into optimal treatment for this rare cancer is warranted.